O-glycosylation of ENO1 at serine 63 by GALNT14 promotes triple-negative breast cancer progression by enhancing ENO1 protein stability. // Biochimica et Biophysica Acta: Molecular Basis of Disease. – URL: https://www.sciencedirect.com/science/article/pii/S0925443926003935?dgcid=rss_sd_all
O-glycosylation of ENO1 at serine 63 by GALNT14 promotes triple-negative breast cancer progression by enhancing ENO1 protein stability. Biochimica et Biophysica Acta: Molecular Basis of Disease. https://www.sciencedirect.com/science/article/pii/S0925443926003935?dgcid=rss_sd_all
“O-glycosylation of ENO1 at serine 63 by GALNT14 promotes triple-negative breast cancer progression by enhancing ENO1 protein stability.” Biochimica et Biophysica Acta: Molecular Basis of Disease.
@article{article37529,
title = {O-glycosylation of ENO1 at serine 63 by GALNT14 promotes triple-negative breast cancer progression by enhancing ENO1 protein stability},
journal = {Biochimica et Biophysica Acta: Molecular Basis of Disease},
url = {https://www.sciencedirect.com/science/article/pii/S0925443926003935?dgcid=rss_sd_all}
}